PROGRAMA PARA LA MEJORA DE CALIDAD DE VIDA EN PACIENTES ONCOLÓGICAS DEL PROGRAMA ¨CLUB DE LA MAMA¨ ATENDIDAS EN EL INSTITUTO NACIONAL MATERNO PERINATAL 2023

Luisa Moreno-Valles; Ermes Manco-Avila; Isabel Huaranca-Berrocal; Paola Chávez-Ochoa; Erika Andrea Porta Pittman; Jennifer Umeres; Ronald Oviedo Bernuy; Daniel Silva-Dominguez

doi:10.33421/inmp.2024382

Autores/as

Luisa Moreno-Valles Instituto Nacional Materno Perinatal, Lima, Perú https://orcid.org/0000-0002-8990-4975
Ermes Manco-Avila Instituto Nacional Materno Perinatal, Lima, Perú https://orcid.org/0000-0002-6278-3915
Isabel Huaranca-Berrocal Instituto Nacional Materno Perinatal, Lima, Perú https://orcid.org/0000-0002-0792-0489
Paola Chávez-Ochoa Instituto Nacional Materno Perinatal, Lima, Perú https://orcid.org/0000-0003-4857-2019
Erika Andrea Porta Pittman Universidad Peruana Cayetano Heredia, Lima, Perú https://orcid.org/0000-0001-5887-1595
Jennifer Umeres Universidad Peruana Cayetano Heredia, Lima, Perú https://orcid.org/0000-0001-9471-7448
Ronald Oviedo Bernuy Universidad Nacional Mayor de San Marcos, Lima, Perú https://orcid.org/0000-0003-4116-9649
Daniel Silva-Dominguez Instituto Nacional Materno Perinatal, Lima, Perú https://orcid.org/0000-0001-8075-6489

DOI:

https://doi.org/10.33421/inmp.2024382

Palabras clave:

Oncología, Calidad de vida, Ansiedad, Estrés, Depresión

Resumen

Objetivo. Evaluar los resultados de un programa para la mejora de la calidad de vida en pacientes oncológicas del ¨Club de la mama¨ atendidas en el INMP (2023). Materiales y Métodos. Esta investigación corresponde a un estudio piloto con un análisis cuasiexperimental, el cual consiste en la aplicación de un programa para la mejora de la calidad de vida en pacientes oncológicas atendidas durante el 2023, se utilizó el total de la población, 7 participantes, con edades entre los 41 y 71 años (media=60.25), aplicándose la totalidad del programa (36 sesiones, 9 meses). Se utilizó la escala de Calidad de Vida (QLQ-30), Ansiedad (GAD-7), Depresión (PHQ-9) y Estrés (PSS-10) en 4 momentos, antes de iniciar el programa (pretest), luego de 3 meses (control 1), posterior a 6 meses (control 2) y por último luego de la aplicación total del programa, 9 meses (control 3). Se realizo el análisis de frecuencias y porcentajes de las variables, ajuste de bondad a la curva normal, y las pruebas de T Student para muestras relacionadas (p>0,05) intragrupo con un nivel de confianza al 95%. Resultados. Se encontró diferencias significativas entre los pretest y controles en sus diferentes variables, Calidad de vida (p<0,05, aumento de 35,29 a 66), Ansiedad (p<0,05, se redujo de 12,86 a 3,71), Depresión (p<0,05, se redujo de 12 a 2,14), y Estrés (p<0,05, se redujo de 28 a 15,14). Conclusión. El programa aplicado en el club de la mama mejoró la calidad de vida de las pacientes oncológicas al finalizar sus sesiones.

Descargas

Los datos de descarga aún no están disponibles.

Referencias

1. Organizacion Mundial de la Salud O. Cancer: Yo soy, y voy a. Organizacion Panamericana de la Salud [Internet]. 2021.

2. Ministerio de Salud M. Situacion del cancer en el Perú, 2021. Centro Nacional de Epidemiologia, Prevencion y control de enfermedades. 2021;10.

3. Grégoire C, Faymonville ME, Jerusalem G, Gosseries O, Vanhaudenhuyse A. Psychooncology interventions focusing on fatigue and sleep disturbances. Current opinion in oncology. 2022;34(4):270-8.

4. Niedzwiedz CL, Knifton L, Robb KA, Katikireddi SV, Smith DJ. Depression and anxiety among people living with and beyond cancer: a growing clinical and research priority. BMC cancer. 2019;19(1):943.

5. Henry BJ. Symptom Management in Oncology: Depression and Anxiety. Seminars in oncology nursing. 2022;38(1):151251.

6. Pitman A, Suleman S, Hyde N, Hodgkiss A. Depression and anxiety in patients with cancer. BMJ (Clinical research ed). 2018;361:k1415.

7. Grassi L. Psychiatric and psychosocial implications in cancer care: the agenda of psycho-oncology. Epidemiology and psychiatric sciences. 2020;29:e89.

8. Güç ZG, Alacacıoğlu A, Yazır MG, Kalender ME, Ünal S, Oflazoğlu U, et al. Being a Cancer Patient during the Time of COVID-19: Impact of the Pandemic on the Anxiety and the Sleeping Quality of Oncology Patients. Chemotherapy. 2022;67(1):29-36.

9. Gonzalez M, Pascoe MC, Yang G, de Manincor M, Grant S, Lacey J, et al. Yoga for depression and anxiety symptoms in people with cancer: A systematic review and meta-analysis. Psycho- oncology. 2021;30(8):1196-208.

10. Lang-Rollin I, Berberich G. Psycho-oncology. Dialogues in clinical neuroscience. 2018;20(1):13-22.

11. Rossetti A, Chadha M, Torres BN, Lee JK, Hylton D, Loewy JV, et al. The Impact of Music Therapy on Anxiety in Cancer Patients Undergoing Simulation for Radiation Therapy. International journal of radiation oncology, biology, physics. 2017;99(1):103-10.

12. Krasne M, Ruddy KJ, Poorvu PD, Gelber SI, Tamimi RM, Schapira L, et al. Coping strategies and anxiety in young breast cancer survivors. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 2022;30(11):9109-16.

13. Loh KP, Kleckner IR, Lin PJ, Mohile SG, Canin BE, Flannery MA, et al. Effects of a Home- based Exercise Program on Anxiety and Mood Disturbances in Older Adults with Cancer Receiving Chemotherapy. Journal of the American Geriatrics Society. 2019;67(5):1005-11.

14. Kwekkeboom KL, Cherwin CH, Lee JW, Wanta B. Mind-body treatments for the pain-fatigue- sleep disturbance symptom cluster in persons with cancer. Journal of pain and symptom management. 2010;39(1):126-38. 15.

15. Grégoire C, Faymonville ME, Vanhaudenhuyse A, Charland-Verville V, Jerusalem G, Bragard Randomized controlled trial of an 8-week intervention combining self-care and hypnosis for post-treatment cancer patients: study protocol. BMC cancer. 2018;18(1):1113.

16. Park S, Sato Y, Takita Y, Tamura N, Ninomiya A, Kosugi T, et al. Mindfulness-Based Cognitive Therapy for Psychological Distress, Fear of Cancer Recurrence, Fatigue, Spiritual Well-Being, and Quality of Life in Patients With Breast Cancer-A Randomized Controlled Trial. Journal of pain and symptom management. 2020;60(2):381-9.

17. Miaskowski C, Mastick J, Paul S, Wallhagen M, Abrams G, Levine JD. Associations among hearing loss, multiple co-occurring symptoms, and quality of life outcomes in cancer survivors. Journal of cancer survivorship : research and practice. 2022:1-10.

18. Rodrigues P, Watson M, White C, Lynch A, Mohammed K, Sagoo GS. Cost-effectiveness analysis of telephone- based cognitive behaviour therapy compared to treatment as usual CBT for cancer patients: Evidence from a small, randomised controlled trial. Psycho- oncology. 2021;30(10):1691-8.

19. Cheng KKF, Lim YTE, Koh ZM, Tam WWS. Home- based multidimensional survivorship programmes for breast cancer survivors. The Cochrane database of systematic reviews. 2017;8(8):Cd011152.

20. Gonzalez-Saenz de Tejada M, Bilbao A, Baré M, Briones E, Sarasqueta C, Quintana JM, et al. Association between social support, functional status, and change in health-related quality of life and changes in anxiety and depression in colorectal cancer patients. Psycho-oncology. 2017;26(9):1263-9.

21. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. 1993;85(5):365-76.

22. Ramirez A, Rúa A. Propiedades psicométricas del cuestionario de calidad de vida QLQ-C3 en pacientes oncológicos. Universidad San Ignacion de Loyola. 2019.

23. Spitzer RL, Kroenke K, Williams JB, Löwe BJAoim. A brief measure for assessing generalized anxiety disorder: the GAD-7. 2006;166(10):1092-7.

24. Franco-Jimenez RA, Nuñez-Magallanes A. Propiedades psicométricas del GAD-7, GAD-2 y GAD-Mini en universitarios peruanos. Propósitos y Representaciones. 2022;10.

25. Kroenke K, Spitzer RL, Williams JBJJogim. The PHQ- 9: validity of a brief depression severity measure. 2001;16(9):606-13.

26. Villarreal-Zegarra D, Copez-Lonzoy A, Bernabé- Ortiz A, Melendez-Torres GJ, Bazo-Alvarez JC. Valid group comparisons can be made with the Patient Health Questionnaire (PHQ-9): A measurement invariance study across groups by demographic characteristics. PloS one. 2019;14(9):e0221717.

27. Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. Journal of Health and Social Behavior. 1983;24(4):385-96.

28. Remor E. Psychometric properties of a European Spanish version of the Perceived Stress Scale (PSS). The Spanish journal of psychology. 2006;9(1):86-93.

29. Canales M, Garcia G. Adaptación de Perceived Stress Scale (PSS-10) en la población de adultos jóvenes de Lima Metropolitana, 2021. Universidad Cesar Vallejo Repositorio. 2021;1.

30. Cramer H, Lauche R, Klose P, Lange S, Langhorst J, Dobos GJ. Yoga for improving health-related quality of life, mental health and cancer-related symptoms in women diagnosed with breast cancer. The Cochrane database of systematic reviews. 2017;1(1):Cd010802.

31. Andersen BL, DeRubeis RJ, Berman BS, Gruman J, Champion VL, Massie MJ, et al. Screening, assessment, and care of anxiety and depressive symptoms in adults with cancer: an American Society of Clinical Oncology guideline adaptation. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2014;32(15):1605-19.

32. McGettigan M, Cardwell CR, Cantwell MM, Tully MA. Physical activity interventions for disease-related physical and mental health during and following treatment in people with non-advanced colorectal cancer. The Cochrane database of systematic reviews. 2020;5(5):Cd012864.

33. Tarrasch J, England P, Hurst VT, McDonald D, O'Keefe R, Cipriano C. Patients With Metastatic Disease Are at Highest Risk for Anxiety and Depression in an Orthopedic Oncology Patient Population. JCO oncology practice. 2022;18(9):e1407-e16.

34. Nardone V, Vinciguerra C, Correale P, Guida C, Tini P, Reginelli A, et al. Music therapy and radiation oncology: State of art and future directions. Complementary therapies in clinical practice. 2020;39:101124.

35. Zeng Y, Zhang JE, Cheng ASK, Cheng H, Wefel JS. Meta-Analysis of the Efficacy of Virtual Reality- Based Interventions in Cancer-Related Symptom Management. Integrative cancer therapies. 2019;18:1534735419871108.

36. Bosman JT, Bood ZM, Scherer-Rath M, Dörr H, Christophe N, Sprangers MAG, et al. The effects of art therapy on anxiety, depression, and quality of life in adults with cancer: a systematic literature review. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 2021;29(5):2289-98.

37. Oberoi S, Yang J, Woodgate RL, Niraula S, Banerji S, Israels SJ, et al. Association of Mindfulness- Based Interventions With Anxiety Severity in Adults With Cancer: A Systematic Review and Meta- analysis. JAMA network open. 2020;3(8):e2012598.